France Allergy Immunotherapy Market is Anticipated to Reach USD 525.9 Million and Growing at a CAGR of 11.59% During Forecast Period 2023 - 2030 | IGR

Infinium Global Research, a leading market research firm, has released an in-depth market research report on the France Allergy Immunotherapy Market, forecasting a significant Compound Annual Growth Rate (CAGR) of 11.59% between 2023 and 2030. The report delves into the key factors driving the growth of allergy immunotherapy in France, while addressing challenges and opportunities within the market. The France allergy immunotherapy market was valued at USD 220.2 Million in 2022 and is expected to reach USD 525.9 Million by 2030 and grow at a CAGR of 11.59% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/13157

The France Allergy Immunotherapy Market is experiencing substantial growth, with the rise in the prevalence of allergic diseases being a primary driver. Factors such as changing lifestyles, food habits, increasing pollution levels, and tobacco consumption contribute to the growth of allergic diseases in France. These factors have led to a significant increase in the demand for allergy immunotherapy, driven by its cost-effectiveness.

Allergic diseases, particularly respiratory allergies, are becoming a major public health concern in France. The prevalence of severe asthma in the adult population is high, indicating a substantial burden of the disease. Allergic rhinitis is also prevalent in asthmatic patients, affecting a significant percentage of them. Additionally, food allergies are on the rise in developed countries like France, with a notable percentage of the population affected by various allergens.

Allergic diseases negatively impact the quality of life of patients, resulting in restrictions on physical activity, absenteeism from work, and a decrease in overall quality of life. This has created a socio-economic burden, leading to a loss of productivity. Allergy immunotherapy has proven to be an effective solution for reducing allergic symptoms and improving the quality of life for patients. Moreover, it is a cost-effective approach, as the social cost of allergic diseases in France amounts to billions of Euros, mainly due to lost productivity. Allergen immunotherapy has been associated with cost savings, reduced pharmaceutical consumption, fewer clinic visits, and increased productivity.

Despite the success of allergy immunotherapy, concerns about its side effects have risen. Subcutaneous immunotherapy (SCIT), one of the most common methods of administration, can lead to immediate local and delayed side effects, with systemic reactions ranging from mild to life-threatening anaphylaxis. The rising concern about these reactions has led to recommendations for patients to receive SCIT under medical supervision, with a mandatory 30-minute monitoring period following the injection. Sublingual immunotherapy (SLIT), another common approach, can result in local side effects, such as oromucosal pruritus or mild local edema, occurring within the first few days of treatment.

To address these concerns, new approaches and therapies have emerged, such as anti-IgE (omalizumab) used in combination with immunotherapy, which have improved safety and efficacy. For example, Xolair® (omalizumab) received approval for self-injection in December 2018, making it the first and only biologic to receive EC approval for self-administration. Future studies are focused on enhancing patient outcomes with safer forms of immunotherapy, utilizing recombinant technology, allergens with reduced allergenicity, and T-cell epitope-based vaccines without reducing immunogenicity. These innovative therapies are expected to drive the France Allergy Immunotherapy Market in the forecast period.

The France Allergy Immunotherapy Market is poised for substantial growth as the prevalence of allergic diseases continues to rise, and innovative approaches promise safer and more effective treatments for patients.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/13157

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Allergy Immunotherapy Market Highlights

2.2. Allergy Immunotherapy Market Projection

2.3. Allergy Immunotherapy Market Regional Highlights

Chapter 3. Global Allergy Immunotherapy Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Type

3.4.2. IGR-Growth Matrix Analysis by Allergy Type

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Allergy Immunotherapy Market

Chapter 4. Allergy Immunotherapy Market Macro Indicator Analysis

Chapter 5. Global Allergy Immunotherapy Market by Type

5.1. SLIT

5.2. SCIT

Chapter 6. Global Allergy Immunotherapy Market by Allergy Type

6.1. Asthma

6.2. Venom Allergy

6.3. Allergic Rhinitis

6.4. Food Allergy

6.5. Others Allergy Type

Chapter 7. Global Allergy Immunotherapy Market by Distribution Channel

7.1. Retail Pharmacy and Drug Stores

7.2. Hospital Pharmacy

7.3. Online Pharmacy

Chapter 8. Global Allergy Immunotherapy Market by Region 2023-2030

8.1. North America

8.1.1. North America Allergy Immunotherapy Market by Type

8.1.2. North America Allergy Immunotherapy Market by Allergy Type

8.1.3. North America Allergy Immunotherapy Market by Distribution Channel

8.1.4. North America Allergy Immunotherapy Market by Country

8.2. Europe

8.2.1. Europe Allergy Immunotherapy Market by Type

8.2.2. Europe Allergy Immunotherapy Market by Allergy Type

8.2.3. Europe Allergy Immunotherapy Market by Distribution Channel

8.2.4. Europe Allergy Immunotherapy Market by Country

8.3. Asia-Pacific

8.3.1. Asia-Pacific Allergy Immunotherapy Market by Type

8.3.2. Asia-Pacific Allergy Immunotherapy Market by Allergy Type

8.3.3. Asia-Pacific Allergy Immunotherapy Market by Distribution Channel

8.3.4. Asia-Pacific Allergy Immunotherapy Market by Country

8.4. RoW

8.4.1. RoW Allergy Immunotherapy Market by Type

8.4.2. RoW Allergy Immunotherapy Market by Allergy Type

8.4.3. RoW Allergy Immunotherapy Market by Distribution Channel

8.4.4. RoW Allergy Immunotherapy Market by Sub-region

Chapter 9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Allergy Immunotherapy Market

9.2. Companies Profiles

9.2.1. Aimmune Therapeutics

9.2.2. Biomay

9.2.3. Stallergenes Greer

9.2.4. Abello

9.2.5. Allergy Therapeutics

9.2.6. Merck

9.2.7. Circassia

9.2.8. HAL Allergy

9.2.9. Anergis

9.2.10. DBV Technologies

Chapter 10. Appendix

10.1.Primary Research Findings and Questionnaire

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/13157

Reasons to Buy this Report:

=> Comprehensive analysis of regional markets of allergy immunotherapy.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.